MBX Biosciences, Inc. (MBX) › Cash & EquivalentsMBX Biosciences, Inc. (MBX) — Cash & EquivalentsAnnual figures by fiscal year, from SEC filings.2023: $30.52M2024: $49.35M2025: $75.29M$75.29M2023Cash & Equivalents (USD)2025Fiscal YearCash & EquivalentsChange YoY2025$75.29M+52.6%2024$49.35M+61.7%2023$30.52M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share